Luxfer Holdings (LXFR) officer gains 5,299 performance-based stock options

Rhea-AI Filing Summary

Luxfer Holdings plc officer Wardlow Graham reported the vesting of performance-based stock options, increasing his derivative holdings through compensation awards rather than open‑market buying. He acquired 3,229 options and 2,070 options, each exercisable 1-for-1 into Ordinary Shares for a nominal $1.00 per share.

These options were originally awarded on March 20, 2023 and fully granted and vested on March 20, 2026 after the company met EPS growth and relative total shareholder return goals for the performance period ended December 31, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wardlow Graham

(Last) (First) (Middle)

LUXFER HOLDINGS PLC

LUMNS LANE

(Street)

MANCHESTER M27 8LN

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
LUXFER HOLDINGS PLC [ LXFR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(1)	03/20/2026		A		3,229		03/20/2026(2)	(2)	Ordinary Shares	3,229	(1)	3,229	D
Stock Options (Right to Buy)	(1)	03/20/2026		A		2,070		03/20/2026(3)	(3)	Ordinary Shares	2,070	(1)	2,070	D

Explanation of Responses:

1. 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.

2. Represents the grant of performance-based Options (at 117% target) awarded on March 20, 2023. 100% of the performance-based Options were granted and vested on March 20, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025.

3. Represents the grant of performance-based Options (at 50% target) awarded on March 20, 2023. 100% of the performance-based Options were granted and vested on March 20, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025.

Remarks:

	/s/ Benjamin Coulson under Power of Attorney for Graham Wardlow	03/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Wardlow Graham report at Luxfer Holdings (LXFR)?

Wardlow Graham reported the vesting of performance-based stock options at Luxfer Holdings. He acquired 3,229 and 2,070 options, each convertible into one Ordinary Share, as part of his compensation rather than through open-market purchases.

How many Luxfer Holdings performance-based options did Wardlow Graham receive?

Wardlow Graham received two performance-based option grants totaling 5,299 options. One grant covered 3,229 options and the other 2,070 options, each representing the right to acquire one Luxfer Holdings Ordinary Share for a nominal $1.00 exercise price.

What performance goals triggered Wardlow Graham’s Luxfer options vesting at LXFR?

The options vested after Luxfer achieved specific performance goals. One grant depended on EPS growth, and the other on relative total shareholder return, over a performance period that ended December 31, 2025, leading to full vesting on March 20, 2026.

When were Wardlow Graham’s Luxfer performance-based options awarded and vested?

The performance-based options were awarded on March 20, 2023 and fully granted and vested on March 20, 2026. Vesting occurred after Luxfer met EPS growth and relative total shareholder return targets for the performance period ending December 31, 2025.

Are Wardlow Graham’s Luxfer option transactions open-market buys or compensation?

These transactions represent compensation-related grants and vesting of stock options, not open-market share purchases. The Form 4 shows options with a nominal $1.00 per-share exercise price, awarded and vested upon meeting pre-set performance goals, rather than discretionary buying.